Survival and FEV1 decline in individuals with severe deficiency of α1-antitrypsin

American Journal of Respiratory and Critical Care Medicine

Volumn 158, Issue 1, 1998, Pages 49-59

  Vreim, C E ^a   Wu, M ^a   Crystal, R G ^a   Buist, A S ^a   Burrows, B ^a   Cohen, A B ^a   Fallat, R J ^a   Gadek, J E ^a   Rousell, R H ^a   Schwartz, R S ^a   Turino, G M ^a   Schluchter, M D ^a   Stoller, J K ^a   Wiedemann, H P ^a   Williams, G W ^a   Barrett, D M ^a   Beck, G J ^a   Midcalf, V ^a   Moore, B ^a   Sartori, P ^a   Sherer, S G ^a   Zhang, R ^a   Petty, T L ^a   Tomashefski J F , Jr ^a   Brantly, M L ^a   Hildesheim, J ^a   Rundquist, B ^a   Sandhaus, R A ^a   Bell, C W ^a   Berend, J ^a   Begle, B ^a   Erb, D ^a   Seidman, J ^a   Sherman, S ^a   Cameron, B ^a   Weinberger, S ^a   Rosenberg, M ^a,a   Johnston, R ^a   Arroliga, A C ^a   Meeker, D P ^a   Mehta, A ^a   Laskowski, D ^a   Ryan, J ^a   Loftin, J P ^a   Johnson, K ^a   Kotch, A ^a   Clark, T ^a   Epstein, P E ^a   Del Buono, P ^a   Sandblom, R E ^a   Hert, R C ^a   DeMaine, J B ^a   Colar, L ^a   Eichenhorn, M S ^a   McMahan, J P ^a   Breite, W M ^a   Webb Johnson, D ^a   Corbett, J ^a   McManus, D ^a   Krowka, M J ^a   Zeiger, T ^a   Prakash, U B ^a   Staats, T ^a   Strange, C ^a   Baumann, M ^a   Judson, M ^a   Oser, R ^a   Soskel, N T ^a   Smith, V ^a   Killian, D N ^a   Demicco, W ^a   Golden, L ^a   Hitchcock, R ^a   Moss, J ^a   Chu, S C ^a   McElvaney, N G ^a   Barnes, P ^a   O'Neil, K ^a   Holden, D ^a   Meth, B M ^a   Ashburn, R W ^a   Forrester, J ^a   Sarlin, R F ^a   Sen, R S ^a   Walsh, T E ^a   Jones, S ^a   Drake, J ^a   more..

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN;

ADULT; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SMOKING; SPIROMETRY; SURVIVAL RATE; TREATMENT INDICATION; TREATMENT OUTCOME; DRUG EFFECT; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PHENOTYPE; PREDICTION AND FORECASTING; SURVIVAL;

ADULT; ALPHA 1-ANTITRYPSIN; ALPHA 1-ANTITRYPSIN DEFICIENCY; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHENOTYPE; PREDICTIVE VALUE OF TESTS; SPIROMETRY; SURVIVAL ANALYSIS;

EID: 0032110436     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.158.1.9712017     Document Type: Article

References (37)